←
Jon Casey187 posts
Jon Casey avatar

Jon Casey

@JonathanCaseyMD
◷ Joined August 2017▧ 1 Photos and videos
Healio Pulmonology avatar
⟳ Jon Casey retweeted
Healio Pulmonology@HealioPulm·19 Dec 2025

💬"Many experts thought that using ketamine might increase the number of patients who survived, compared to etomidate — but it did not,” @JonathanCaseyMD & Dr. Matthew W. Semler of @VUMCDiscoveries told Healio. #intubation healio.com/news/pulmonology/…

Healio Pulmonology avatar
⟳ Jon Casey retweeted
Healio Pulmonology@HealioPulm·18 Dec 2025

Published in @NEJM: In-hospital🏥 mortality by day 28 did not significantly differ based on use of ketamine or etomidate to induce anesthesia in critically ill adults undergoing #intubation.   healio.com/news/pulmonology/…   @JonathanCaseyMD @VUMCDiscoveries

NEJM avatar
⟳ Jon Casey retweeted
NEJM@NEJM·10 Dec 2025

Presented at CCR Down Under 2025: In a randomized trial involving critically ill patients undergoing intubation in EDs or ICUs, the use of ketamine for the induction of anesthesia did not lead to significantly lower in-hospital mortality than etomidate. Full trial results: nej.md/44EOlxB @CritCareReviews

Post attachment
Nick Mark MD avatar
⟳ Jon Casey retweeted
Nick Mark MD@nickmmark·10 Dec 2025

💉 The results of the RSI Trial results are in and they are truly practice changing! By choosing etomidate over ketamine: NNT=20 to prevent cardiovascular collapse! 🪦RIP Ketamine for Endotracheal intubation induction! #CCRDownUnder

Post attachment
ICUEdandToddCast avatar
⟳ Jon Casey retweeted
ICUEdandToddCast@IcuCast·10 Dec 2025

Got the post #CCRDownUnder blues? Listen to our interview and deep dive of the RSI trial with @JonathanCaseyMD, recently published in @NEJM icuedandtoddcast.buzzsprout.…

the EMCrit Crew avatar
⟳ Jon Casey retweeted
the EMCrit Crew@emcrit·10 Dec 2025

EMCrit Wee - The RSI Trial - Etomidate vs. Ketamine for RSI Induction in the critically ill. These results are practice changing for many resuscitationists! I know it will change my practice. Listen to this interview with lead authors: @JonathanCaseyMD and @brian_driver [#FOAMed for now!]

Post attachment
the EMCrit Crew avatar
⟳ Jon Casey retweeted
the EMCrit Crew@emcrit·6 Dec 2025

On Dec 9th, as soon as the embargo lifts, I will publish an EMCrit Wee on the Results of the RSI trial-Etomidate vs. Ketamine for RSI Induction. It is a discussion with the lead authors: @JonathanCaseyMD and @brian_driver Until then, why don't you put your chips down!!! Take this 30 second survey to lock in your predictions of the results redcap.link/rsitrialresults

Post attachment
Todd Rice avatar
⟳ Jon Casey retweeted
Todd Rice@toddrice_ICU·1 Jul 2025

Awesome to have Dr. Seitz join us to talk about MODE and the upcoming MODEM trials. Ventilators have many different modes, and while we often spend time understanding how each mode works, understanding how different modes might affect our patients and outcomes is more difficult.

Episode 68! Today we talk about modes of mechanical ventilation with the first author Dr. Kevin Seitz. This was published in @accpchest April of 2025 🎧: pod.link/1667336877 Pubmed: pubmed.ncbi.nlm.nih.gov/4018…

M Velia Antonini avatar
⟳ Jon Casey retweeted
M Velia Antonini@FOAMecmo·14 Mar 2025

Low vs moderate-intensity anticoagulation for VV #ECMO 🔍 SAFE-ECMO pilot trial; 3 centers across 🇺🇸 💉 intermittent SC anticoagulant (doses for DVT prophylaxis) vs traditional approach to anticoagulation with continuous, goal-titrated, infusion 🩸major bleedings 8.3% in low vs 28.6% in moderate-intensity group 🩸thromboembolic event 8.3% vs none 🪦 mortality before discharge 0 vs 14.3% @accpchest 🖇️ bit.ly/3DLsiLF

Post attachment